Sp1 and COX2 expression is positively correlated with a poor prognosis in pancreatic ductal adenocarcinoma

Previous studies showed that celecoxib, a cyclooxygenase-2 (COX2) inhibitor, can inhibit angiogenesis and metastasis of pancreatic ductal adenocarcinoma (PDAC) via the suppression of specificity protein 1 (Sp1). In this study, we investigated the prognostic value of Sp1 and COX2 in 88 PDAC patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Hang, Junjie, Hu, Hai, Huang, Junjie, Han, Ting, Zhuo, Meng, Zhou, Yangyang, Wang, Lei, Wang, Yi, Jiao, Feng, Wang, Liwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053721/
https://www.ncbi.nlm.nih.gov/pubmed/27057636
http://dx.doi.org/10.18632/oncotarget.8593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053721/
https://www.ncbi.nlm.nih.gov/pubmed/27057636
http://dx.doi.org/10.18632/oncotarget.8593

Ejemplares similares